On September 21, 36Kr Venture Capital Research Institute released its annual list for 2022. C&D Emerging Industry Equity Investment Co., Ltd. won the awards of “China’s Top20 Marketization Fund of Funds voted by General Partners” for the third consecutive year, “China’s Top10 Fund of Funds Direct Investment in Equity Investment Market” for the second consecutive year, and “China’s Top10 Secondary Fund in Equity Investment Market” for the first time.

In addition, the company participated in the Legend Xinhai Fund and the Eastern Bell Capital RMB Phase 5 Fund among the “China’s Home Market Top10 Best Return Fund”, and participated in three cases of CATL, Pharmaron and Bloomage BioTechnology among the “China’s Home Market Top10 Best Return Star Cases”.